LRAT Antikörper (N-Term)
Kurzübersicht für LRAT Antikörper (N-Term) (ABIN929344)
Target
Alle LRAT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- LRAT antibody was raised in rabbit using the N terminal of LRAT as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
LRAT Blocking Peptide, (ABIN940320), is also available for use as a blocking control in assays to test for specificity of this LRAT antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LRAT (Lecithin Retinol Acyltransferase (Phosphatidylcholine--Retinol O-Acyltransferase) (LRAT))
-
Andere Bezeichnung
- LRAT
-
Hintergrund
- The protein encoded by this gene is a microsomal enzyme that catalyzes the esterification of all-trans-retinol into all-trans-retinyl ester, an essential reaction for the retinoid cycle in visual system and vitamin A status in liver. Mutations in this gene have been associated with early-onset severe retinal dystrophy. Synonyms: Polyclonal LRAT antibody, Anti-LRAT antibody, lecithin retinol acyltransferase, phosphatidylcholine--retinol O-acyltransferase antibody, MGC33103 antibody.
Target
-